Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement

Kathleen I. Pritchard; K. A. Gelmon; D. Rayson; L. Provencher; M. Webster; D. McLeod; S. Verma

doi:10.3747/co.20.1316

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement

Kathleen I. Pritchard, K. A. Gelmon, D. Rayson, L. Provencher, M. Webster, D. McLeod, S. Verma

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	48-61
Number of pages	14
Journal	Current Oncology
Volume	20
Issue number	1
DOIs	https://doi.org/10.3747/co.20.1316
Publication status	Published - 2013
Externally published	Yes

ASJC Scopus Subject Areas

Oncology

Keywords

Advanced breast cancer
Endocrine resistance
Endocrine therapy
Everolimus
Exemestane
Fulvestrant
Mtorinhibitor
Nonsteroidal aromatase inhibitor

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3747/co.20.1316

Fingerprint

Dive into the research topics of 'Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement'. Together they form a unique fingerprint.

Cite this

Pritchard, K. I., Gelmon, K. A., Rayson, D., Provencher, L., Webster, M., McLeod, D., & Verma, S. (2013). Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement. Current Oncology, 20(1), 48-61. https://doi.org/10.3747/co.20.1316

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement. / Pritchard, Kathleen I.; Gelmon, K. A.; Rayson, D. et al.
In: Current Oncology, Vol. 20, No. 1, 2013, p. 48-61.

Research output: Contribution to journal › Article › peer-review

Pritchard, KI, Gelmon, KA, Rayson, D, Provencher, L, Webster, M, McLeod, D & Verma, S 2013, 'Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement', Current Oncology, vol. 20, no. 1, pp. 48-61. https://doi.org/10.3747/co.20.1316

@article{8199868eb0644311b8100a612a4b8483,

title = "Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement",

keywords = "Advanced breast cancer, Endocrine resistance, Endocrine therapy, Everolimus, Exemestane, Fulvestrant, Mtorinhibitor, Nonsteroidal aromatase inhibitor",

author = "Pritchard, {Kathleen I.} and Gelmon, {K. A.} and D. Rayson and L. Provencher and M. Webster and D. McLeod and S. Verma",

year = "2013",

doi = "10.3747/co.20.1316",

language = "English",

volume = "20",

pages = "48--61",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multimed Inc.",

number = "1",

}

TY - JOUR

T1 - Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy

T2 - A canadian consensus statement

AU - Pritchard, Kathleen I.

AU - Gelmon, K. A.

AU - Rayson, D.

AU - Provencher, L.

AU - Webster, M.

AU - McLeod, D.

AU - Verma, S.

PY - 2013

Y1 - 2013

KW - Advanced breast cancer

KW - Endocrine resistance

KW - Endocrine therapy

KW - Everolimus

KW - Exemestane

KW - Fulvestrant

KW - Mtorinhibitor

KW - Nonsteroidal aromatase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84873444298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873444298&partnerID=8YFLogxK

U2 - 10.3747/co.20.1316

DO - 10.3747/co.20.1316

M3 - Article

AN - SCOPUS:84873444298

SN - 1198-0052

VL - 20

SP - 48

EP - 61

JO - Current Oncology

JF - Current Oncology

IS - 1

ER -

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: A canadian consensus statement

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this